Somatic mutations in telomerase promoter counterbalance germline loss-of-function mutations

Lindley Maryoung, Yangbo Yue, Ashley Young, Chad A. Newton, Cindy Barba, Nicolai S C Van Oers, Richard C. Wang, Christine Kim Garcia

Research output: Contribution to journalArticlepeer-review

43 Scopus citations


Germline coding mutations in different telomere-related genes have been linked to autosomal-dominant familial pulmonary fibrosis. Individuals with these inherited mutations demonstrate incomplete penetrance of clinical phenotypes affecting the lung, blood, liver, skin, and other organs. Here, we describe the somatic acquisition of promoter mutations in telomerase reverse transcriptase (TERT) in blood leukocytes of approximately 5% of individuals with inherited loss-of-function coding mutations in TERT or poly(A)-specific ribonuclease (PARN), another gene linked to telomerase function. While these promoter mutations were initially identified as oncogenic drivers of cancer, individuals expressing the mutations have no history of cancer. Neither promoter mutation was found in population-based cohorts of similar or advanced age. The TERT promoter mutations were found more frequently in cis with the WT allele than the TERT coding sequence mutation. EBVtransformed lymphoblastoid B cell lines (LCLs) derived from subjects with TERT promoter mutations showed increased telomerase expression and activity compared with cell lines from family members with identical coding mutations. TERT promoter mutations resulted in an increased proliferation of LCLs and demonstrated positive selection over time. The persistence and recurrence of noncoding gain-of-function mutations in these cases suggests that telomerase activation is not only safely tolerated but also advantageous for clonal expansion.

Original languageEnglish (US)
Pages (from-to)982-986
Number of pages5
JournalJournal of Clinical Investigation
Issue number3
StatePublished - Mar 1 2017

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Somatic mutations in telomerase promoter counterbalance germline loss-of-function mutations'. Together they form a unique fingerprint.

Cite this